Description: RespireRX Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain-mediated breathing disorders.
Home Page: www.respirerx.com
126 Valley Road
Glen Rock,
NJ
07452
United States
Phone:
201 444 4947
Officers
| Name | Title |
|---|---|
| Dr. Arnold S. Lippa Ph.D. | Exec. Chairman, Interim Pres, Interim CEO & Chief Scientific Officer |
| Dr. Jeff Eliot Margolis | Sr. VP, CFO, Treasurer, Sec. & Director |
| Mr. Richard D. Purcell | Sr. VP of R&D |
| Mr. David Dickason | Sr. VP of Pre-Clinical Product Devel. |
| Mr. Marc M. Radin | Controller |
| Dr. Arvid Carlsson | Consultant |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 1051.0359 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2 |